Lorem
ipsum
Fungal biopolymers for health, nutrition and personal care applications.
Domains
From a single fungal biopolymer platform, we develop targeted solutions for diverse applications across health, nutrition, and personal care.
Our brands
our fungal chitosan holds an EFSA-approved health claim for fat binding and an FDA GRAS classification, two of the most demanding regulatory benchmarks in the industry.
our fungal chitin-glucan, a biopolymer we discovered and patented, is approved as a Novel Food in the EU and supported by clinical evidence in gut health and cardiovascular markers.
our chitosan derivatives are certified by ECOCERT GREENLIFE and compliant with the COSMOS standard to cover skin, hair, oral care, wound care, and sun protection with a single non-animal biopolymer platform.
our manufacturing operates under ISO 13485, the quality standard that wound care and hemostatic applications require.
One platform.
Multiple functions.
An industrial-scale expertise.
Supporting your development with science.
KitOzyme combines analytical characterization, formulation testing, preclinical research, and clinical studies, with the regulatory and quality documentation to support your development across multiple markets.
Available upon request
Fungal chitosan is a non-animal biopolymer produced by fermentation from the cell walls of Aspergillus niger, offering a vegan, allergen-free alternative to shellfish-derived chitosan.
Recommended dosage depends on the application and the target claim. Our technical team provides formulation guidance and clinical references on request.
Yes. Our fungal biopolymers are non-animal, allergen-free and suitable for vegan, halal and kosher formulations.